Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Birth Defects Research. Part A, Clinical and Molecular Teratology|April 1, 2006
Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolismWeizhi Zhao, Bridget S Mosley, Mario A Cleves, et al.
Journal of Translational Medicine|February 18, 2025
Identification of pro-fibrotic cellular subpopulations in fascia of gluteal muscle contracture using single-cell RNA sequencingWeizhi Zhao, Zongchao Li, Suzhen Ma, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 22, 2011
Maternal DNA hypomethylation and congenital heart defectsShimul Chowdhury, Mario A Cleves, Stewart L MacLeod, et al.
Frontiers in Genetics|October 30, 2023
Unidirectional alteration of methylation and hydroxymethylation at the promoters and differential gene expression in oral squamous cell carcinomaWeizhi Zhao, Lin Zhu, Qian Gong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implicationsMarisa H Miceli, Monica L Grazziutti, Gail Woods, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 25, 2004
Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defectsMario A Cleves, Van H Savell, Sarika Raj, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 26, 2025
High-Speed, Maneuverable, and Terrain-Adaptive Micro-Robot with Tree Frog-Inspired Bionic FeetWeizhi Zhao, Shijia Li, Kaiwen Zhang, et al.
Journal of Hepatology|June 28, 2025
Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitisArun J Sanyal, Jorg Taubel, Prajakta Badri, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 15, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extensionCécile Cauquil, David Adams, Julian Gillmore, et al.
Neurology and Therapy|March 4, 2026
Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-AJeeyoung Oh, Yoshiki Sekijima, Hideki Mochizuki, et al.
Pageof 3